Injectable buprenorphine study for opioid dependence
Part of Mental health clinical trials.
This trial looks at a long-acting injectable medicine (buprenorphine, also known as BUP) for treating opioid dependence. It aims to see if this approach is acceptable, works well, and is cost-effective compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with opioid dependence by a doctor.
- You are not pregnant and have a negative pregnancy test.
- You are eligible for opioid addiction treatment at a participating clinic.
- You are willing to follow the clinic's rules and attend appointments.
- You can understand the study and give your consent to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a long-acting, once-monthly injection of buprenorphine (BRIXADI) given from a mobile pharmacy clinic. It aims to see if this approach is acceptable and practical for people with opioid use disorder, making treatment more accessible.
This trial compares taking buprenorphine by mouth versus as an injection for opioid use disorder. It aims to see which option helps people stay on treatment and reduces opioid use over about a year.
This study tests whether a once-monthly injection of buprenorphine (called extended-release buprenorphine, or XR-B) works well for people in prison who are already in a medication program for opioid use disorder. It looks at preferences and outcomes in the last months before release.
This study tests two different forms of buprenorphine (a medication for opioid addiction) to see which works better for people who use fentanyl or other strong synthetic opioids. If you are seeking treatment for opioid use, this trial may help you find the most effective option.
This study tests a faster way to start buprenorphine (a medication for opioid use disorder) by using naloxone to briefly trigger mild withdrawal. This could help people get started on treatment more comfortably and quickly.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
Hear when a new Opioid Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.